| scholarly article | Q13442814 |
| P2093 | author name string | Stephan Beck | |
| Nigel P Carter | |||
| Vardhman Rakyan | |||
| Heike Fiegler | |||
| Philippos C Patsalis | |||
| Klea Lamnissou | |||
| Elisavet A Papageorgiou | |||
| Maj Hulten | |||
| P2860 | cites work | Size distributions of maternal and fetal DNA in maternal plasma. | Q47432593 |
| Circulating cell-free fetal DNA in maternal serum appears to originate from cyto- and syncytio-trophoblastic cells. Case report | Q48004844 | ||
| Candidate epigenetic biomarkers for non-invasive prenatal diagnosis of Down syndrome | Q56765605 | ||
| Presence of fetal DNA in maternal plasma and serum | Q57075132 | ||
| Systematic Search for Placental DNA-Methylation Markers on Chromosome 21: Toward a Maternal Plasma-Based Epigenetic Test for Fetal Trisomy 21 | Q58029321 | ||
| Differential DNA methylation between fetus and mother as a strategy for detecting fetal DNA in maternal plasma | Q77372981 | ||
| Bisulfite genomic sequencing: systematic investigation of critical experimental parameters | Q24555629 | ||
| An integrated resource for genome-wide identification and analysis of human tissue-specific differentially methylated regions (tDMRs) | Q24655589 | ||
| Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood | Q24657306 | ||
| SW-ARRAY: a dynamic programming solution for the identification of copy-number changes in genomic DNA using array comparative genome hybridization data | Q24810415 | ||
| Genome-wide location and function of DNA binding proteins | Q28131765 | ||
| Prenatal Diagnosis of Fetal RhD Status by Molecular Analysis of Maternal Plasma | Q28314918 | ||
| Chromosome-wide and promoter-specific analyses identify sites of differential DNA methylation in normal and transformed human cells | Q29618090 | ||
| Hypermethylation of RASSF1A in human and rhesus placentas | Q33275493 | ||
| Detection of the placental epigenetic signature of the maspin gene in maternal plasma. | Q34078379 | ||
| Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. | Q34385131 | ||
| Rapid and simple prenatal diagnosis of common chromosome disorders: advantages and disadvantages of the molecular methods FISH and QF-PCR. | Q35216798 | ||
| High-throughput screening of chromatin immunoprecipitates using CpG-island microarrays | Q35671786 | ||
| Epigenomics: beyond CpG islands. | Q35778671 | ||
| Noninvasive prenatal diagnosis of fetal Rhesus D: ready for Prime(r) Time | Q36274725 | ||
| Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma | Q37010246 | ||
| Detection of cell free placental DNA in maternal plasma: direct evidence from three cases of confined placental mosaicism | Q43073795 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | DNA methylation | Q874745 |
| diagnosis | Q16644043 | ||
| P304 | page(s) | 1609-1618 | |
| P577 | publication date | 2009-04-06 | |
| P1433 | published in | The American Journal of Pathology | Q4744259 |
| P1476 | title | Sites of differential DNA methylation between placenta and peripheral blood: molecular markers for noninvasive prenatal diagnosis of aneuploidies | |
| P478 | volume | 174 |
| Q37433730 | A new method for non-invasive prenatal diagnosis of Down syndrome using MeDIP real time qPCR. |
| Q51346655 | A new non-invasive prenatal diagnosis of Down syndrome through epigenetic markers and real-time qPCR. |
| Q44176018 | Author's response regarding "MeDIP-qPCR approach for non-invasive prenatal diagnosis of Down syndrome: accuracy and reproducibility". |
| Q35738581 | Bisulfite Conversion of DNA: Performance Comparison of Different Kits and Methylation Quantitation of Epigenetic Biomarkers that Have the Potential to Be Used in Non-Invasive Prenatal Testing |
| Q35094123 | Chromosome-wide DNA methylation analysis predicts human tissue-specific X inactivation |
| Q98735793 | Circulating Cell-Free Nucleic Acids as Epigenetic Biomarkers in Precision Medicine |
| Q36790198 | Circulating nucleic acids in plasma and serum: applications in diagnostic techniques for noninvasive prenatal diagnosis |
| Q39003554 | Current and Emerging Technologies for the Analysis of the Genome-Wide and Locus-Specific DNA Methylation Patterns |
| Q88990659 | Current approaches on non-invasive prenatal diagnosis: Prenatal genomics, transcriptomics, personalized fetal diagnosis |
| Q38205768 | DNA methylation as an early diagnostic marker of cancer (Review). |
| Q39656974 | DNA methylation contributes to the tissue-specific expression of the rPL-Iv gene |
| Q37961785 | DNA methylation profiling highlights the unique nature of the human placental epigenome. |
| Q37963517 | DNA methylation testing and marker validation using PCR: diagnostic applications. |
| Q50650841 | DNA methylome profiling of maternal peripheral blood and placentas reveal potential fetal DNA markers for non-invasive prenatal testing. |
| Q34314087 | DNA-methylation profiling of fetal tissues reveals marked epigenetic differences between chorionic and amniotic samples |
| Q34921561 | Determination of fetal chromosome aberrations from fetal DNA in maternal blood: has the challenge finally been met? |
| Q34239768 | Differential DNA methylation as a tool for noninvasive prenatal diagnosis (NIPD) of X chromosome aneuploidies |
| Q35020525 | Discovery of epigenetic biomarkers for the noninvasive diagnosis of fetal disease |
| Q35084533 | Disease specific characteristics of fetal epigenetic markers for non-invasive prenatal testing of trisomy 21 |
| Q34558118 | Epigenetic approaches for the detection of fetal DNA in maternal plasma |
| Q33797671 | Epigenetic-genetic chromosome dosage approach for fetal trisomy 21 detection using an autosomal genetic reference marker |
| Q36103371 | Epigenetics and microRNAs in preeclampsia |
| Q92028423 | Evaluation and statistical optimization of a method for methylated cell-free fetal DNA extraction from maternal plasma |
| Q50052174 | Evaluation of extraction methods for methylated cell-free fetal DNA from maternal plasma |
| Q34059853 | Evidence for widespread changes in promoter methylation profile in human placenta in response to increasing gestational age and environmental/stochastic factors |
| Q42877106 | Feasibility of fetal-derived hypermethylated RASSF1A sequence quantification in maternal plasma--next step toward reliable non-invasive prenatal diagnostics |
| Q34168875 | Fetal-specific DNA methylation ratio permits noninvasive prenatal diagnosis of trisomy 21. |
| Q35158316 | Genome-wide mapping of imprinted differentially methylated regions by DNA methylation profiling of human placentas from triploidies |
| Q34765333 | Global DNA hypermethylation in down syndrome placenta |
| Q37702944 | Global and gene-specific DNA methylation across multiple tissues in early infancy: implications for children's health research |
| Q38262952 | Implementation of whole genome massively parallel sequencing for noninvasive prenatal testing in laboratories |
| Q37342948 | Inactive X chromosome-specific reduction in placental DNA methylation |
| Q34568851 | Inter-individual methylation variability in differentially methylated regions between maternal whole blood and first trimester CVS. |
| Q41496938 | MeDIP Real-Time qPCR has the Potential for Noninvasive Prenatal Screening of Fetal Trisomy 21. |
| Q55424345 | MeDIP combined with in-solution targeted enrichment followed by NGS: Inter-individual methylation variability of fetal-specific biomarkers and their implementation in a proof of concept study for NIPT. |
| Q35082758 | Mrassf1a-pap, a novel methylation-based assay for the detection of cell-free fetal DNA in maternal plasma |
| Q37181536 | Non invasive prenatal diagnosis of aneuploidy: next generation sequencing or fetal DNA enrichment? |
| Q26827338 | Non-Invasive Prenatal Testing Using Cell Free DNA in Maternal Plasma: Recent Developments and Future Prospects |
| Q34149751 | Non-invasive aneuploidy detection using free fetal DNA and RNA in maternal plasma: recent progress and future possibilities |
| Q36424760 | Non-invasive prenatal diagnosis of aneuploidies: new technologies and clinical applications |
| Q82261782 | Non-invasive prenatal diagnosis of trisomy 21 by dosage ratio of fetal chromosome-specific epigenetic markers in maternal plasma |
| Q38114375 | Non-invasive prenatal testing for aneuploidy: current status and future prospects |
| Q37809342 | Noninvasive Approaches to Prenatal Diagnosis of Hemoglobinopathies Using Fetal DNA in Maternal Plasma |
| Q22242878 | Noninvasive detection of fetal trisomy 21: systematic review and report of quality and outcomes of diagnostic accuracy studies performed between 1997 and 2012 |
| Q37998943 | Noninvasive prenatal diagnosis empowered by high-throughput sequencing |
| Q28742844 | Noninvasive prenatal diagnosis of fetal trisomy 18 and trisomy 13 by maternal plasma DNA sequencing |
| Q43530640 | Promoter hypomethylation of COMT in human placenta is not associated with the development of pre-eclampsia |
| Q30987480 | Quantification of Fetal DNA by Use of Methylation-Based DNA Discrimination |
| Q34308038 | Screening significantly hypermethylated genes in fetal tissues compared with maternal blood using a methylated-CpG island recovery assay-based microarray |
| Q51907453 | Stem cell DNA methylation: a consequence of intrauterine growth restriction. |
| Q33836781 | Structural and regulatory characterization of the placental epigenome at its maternal interface |
| Q33770229 | Systematic identification of placental epigenetic signatures for the noninvasive prenatal detection of Edwards syndrome |
| Q56001885 | Technical concerns about immunoprecipitation of methylated fetal DNA for noninvasive trisomy 21 diagnosis |
| Q33891689 | The Epigenome View: An Effort towards Non-Invasive Prenatal Diagnosis |
| Q26995586 | Tracking fetal development through molecular analysis of maternal biofluids |
| Q35595108 | Whole genome bisulfite sequencing of cell-free DNA and its cellular contributors uncovers placenta hypomethylated domains |
| Q47949994 | Whole-genome fetal and maternal DNA methylation analysis using MeDIP-NGS for the identification of differentially methylated regions. |
Search more.